These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2168032)
1. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study. Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032 [TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast. Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells]. Uporov AV; Tsyrlina EV; Pozharisskiĭ KM Vopr Onkol; 1998; 44(3):316-24. PubMed ID: 9695779 [TBL] [Abstract][Full Text] [Related]
4. Proliferative activity is a significant prognostic factor in male breast carcinoma. Pich A; Margaria E; Chiusa L Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830 [TBL] [Abstract][Full Text] [Related]
5. [Histochemical and histomorphometric studies on growth fractions in human breast carcinoma]. Hahn J; Linhart W; Müller H; Renz S; Schneider M Verh Dtsch Ges Pathol; 1990; 74():262-7. PubMed ID: 1708598 [TBL] [Abstract][Full Text] [Related]
6. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry. Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814 [TBL] [Abstract][Full Text] [Related]
7. Nucleolar organizer regions in human breast cancer. Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120 [TBL] [Abstract][Full Text] [Related]
8. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754 [TBL] [Abstract][Full Text] [Related]
9. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects. Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059 [TBL] [Abstract][Full Text] [Related]
10. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer]. Zhao T; Zhang YL; Li CD Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415 [TBL] [Abstract][Full Text] [Related]
11. Vimentin--a new prognostic parameter in breast carcinoma? Raymond WA; Leong AS J Pathol; 1989 Jun; 158(2):107-14. PubMed ID: 2547048 [TBL] [Abstract][Full Text] [Related]
12. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm. Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer. Kakeji Y; Korenaga D; Tsujitani S; Haraguchi M; Maehara Y; Sugimachi K Cancer Res; 1991 Jul; 51(13):3503-6. PubMed ID: 2054789 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483 [TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions. Hasnan J; Jayaram G Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223 [TBL] [Abstract][Full Text] [Related]
16. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications. Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659 [TBL] [Abstract][Full Text] [Related]
17. Argyrophilic staining for nucleolar organizer region (AgNOR). A suitable methodology for differential diagnosis of breast lesions? Sivrides E; Anastasiadis P; von Lüdinghausen M Zentralbl Pathol; 1992 Apr; 138(2):103-7. PubMed ID: 1610761 [TBL] [Abstract][Full Text] [Related]
18. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables. Frierson HF Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204 [TBL] [Abstract][Full Text] [Related]
20. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies. Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]